Coverage on shares of JPMorgan Chase (NYSE:JPM), Immunomedics (NASDAQ:IMMU), MAKO Surgical (NASDAQ:MAKO) and Motorola Mobility (NYSE:MMI) was initiated by analysts.
Cowen initiated coverage on Immunomedics (IMMU), starting them off with an "Outperform" rating.
Stifel Nicolaus initiated coverage on JPMorgan Chase (JPM), starting them off with a "Hold" rating.
William Blair initiated coverage on MAKO Surgical (MAKO), starting them off with an "Outperform " rating.
ThinkEquity initiated coverage on Motorola Mobility (MMI), starting them off with a "Buy" rating.
Showing posts with label Mako Surgical. Show all posts
Showing posts with label Mako Surgical. Show all posts
Friday, May 20, 2011
Tuesday, May 17, 2011
Coverage on (SD) (KWR) (LINE) (MAKO) (NKTR) Initiated
Coverage on SandRidge Energy Inc. (NYSE: SD), Quaker Chemical Co. (NYSE: KWR), Linn Energy, LLC (NASDAQ: LINE), MAKO Surgical (NASDAQ: MAKO) and Nektar Therapeutics (NASDAQ: NKTR) was initiated by analysts.
Morgan Keegan initiated coverage on SandRidge Energy Inc. (SD). They placed an “outperform” rating and a price target of $18.00 on the company.
Keybanc analysts initiated coverage on shares of Quaker Chemical Co. (KWR). They placed a “buy” rating and a price target of $50.00 on the company.
Madison Williams analysts initiated coverage on shares of Linn Energy, LLC (LINE). They placed a “buy” rating and a price target of $45.00 on the company.
Goldman Sachs (NYSE:GS) initiated coverage on MAKO Surgical (MAKO). They placed a “buy” rating on the company.
Boenning & Scattergood initiated coverage on Nektar Therapeutics (NKTR). They placed an “outperform” rating and a price target of $15.00 on the company.
Morgan Keegan initiated coverage on SandRidge Energy Inc. (SD). They placed an “outperform” rating and a price target of $18.00 on the company.
Keybanc analysts initiated coverage on shares of Quaker Chemical Co. (KWR). They placed a “buy” rating and a price target of $50.00 on the company.
Madison Williams analysts initiated coverage on shares of Linn Energy, LLC (LINE). They placed a “buy” rating and a price target of $45.00 on the company.
Goldman Sachs (NYSE:GS) initiated coverage on MAKO Surgical (MAKO). They placed a “buy” rating on the company.
Boenning & Scattergood initiated coverage on Nektar Therapeutics (NKTR). They placed an “outperform” rating and a price target of $15.00 on the company.
Wednesday, January 5, 2011
Mako Surgical (Nasdaq: MAKO), Wright Medical Group (Nasdaq:WMGI) And Healthcare Sector
Mako Surgical (Nasdaq:MAKO) and Wright Medical Group (Nasdaq:WMGI) were listed as the favorite and worst in the medical group coverage network of Brigantine Advisors.
Brigantine said, "The S&P 500 Index returned +12.8% in 2010 (+15.1% including dividends), with all 10 economic sectors in positive territory led by the consumer discretionary (+25.7%), industrials (+23.9%) and materials (+19.9%) groups. The healthcare sector was the worst performing category, rising only 0.71% including a loss of 3.9% for the medical equipment subcategory. However, the bifurcated nature of the market was pronounced in 2010, with the S&P MidCap 400 Index surging 24.9% and the S&P SmallCap 600 gaining 25.0%."
"On the long side, Brigantine Advisors continues to favor names with disruptive medical technology, strong market positioning and the opportunity to create new therapeutic protocols. Conversely, we believe the macro environment will not support a dramatic recovery in surgical procedure volumes in 2011, particularly in the orthopedics category, and given our expectation for more intense pricing pressures we believe many stocks in the group will struggle to generate alpha should investors continue to shift their focus to riskier assets and more cyclical sectors."
"Top picks for 2011: Our favorite long idea is Mako Surgical (Buy), a developer of the Robotic Arm Interactive Orthopedic (RIO) surgery system currently utilized in partial and total knee replacement surgery with potential applications in hip replacement and other orthopedic procedures. Our price target on MAKO is $25. Conversely, we have a Sell rating on Wright Medical Group (Sell), an orthopedic implant manufacturer with exposure to the hip, knee, extremity and biologics categories, and maintain our $13 price target on the stock."
Mako Surgical was trading at $14.53, down $0.07, or 0.48 percent, as of 11:56 AM EST. Wright Medical Group was trading at $16.37, down $0.01, or 0.06 percent.
Brigantine said, "The S&P 500 Index returned +12.8% in 2010 (+15.1% including dividends), with all 10 economic sectors in positive territory led by the consumer discretionary (+25.7%), industrials (+23.9%) and materials (+19.9%) groups. The healthcare sector was the worst performing category, rising only 0.71% including a loss of 3.9% for the medical equipment subcategory. However, the bifurcated nature of the market was pronounced in 2010, with the S&P MidCap 400 Index surging 24.9% and the S&P SmallCap 600 gaining 25.0%."
"On the long side, Brigantine Advisors continues to favor names with disruptive medical technology, strong market positioning and the opportunity to create new therapeutic protocols. Conversely, we believe the macro environment will not support a dramatic recovery in surgical procedure volumes in 2011, particularly in the orthopedics category, and given our expectation for more intense pricing pressures we believe many stocks in the group will struggle to generate alpha should investors continue to shift their focus to riskier assets and more cyclical sectors."
"Top picks for 2011: Our favorite long idea is Mako Surgical (Buy), a developer of the Robotic Arm Interactive Orthopedic (RIO) surgery system currently utilized in partial and total knee replacement surgery with potential applications in hip replacement and other orthopedic procedures. Our price target on MAKO is $25. Conversely, we have a Sell rating on Wright Medical Group (Sell), an orthopedic implant manufacturer with exposure to the hip, knee, extremity and biologics categories, and maintain our $13 price target on the stock."
Mako Surgical was trading at $14.53, down $0.07, or 0.48 percent, as of 11:56 AM EST. Wright Medical Group was trading at $16.37, down $0.01, or 0.06 percent.
Subscribe to:
Posts (Atom)